Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Wedelia trilobata flower extract could be a valuable ingredient for skin care products due to its antioxidant, antimicrobial, and anti-inflammatory properties.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Tetrathelmis tetrathele extract may help prevent hair loss and improve scalp health.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Entospletinib effectively prevents eye and skin GVHD in mice.

Thymoma with alopecia areata may be linked to abnormal immune cells.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

New insights into skin damage from UV exposure suggest potential treatments, including targeting specific RNAs and combining therapies for better outcomes.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Nanomaterials show promise in improving wound healing but require more research on their potential toxicity.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Granulomatous Alopecia Areata is rare and may be caused by hair antigens or follicle destruction.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.